관련 키워드샤페론누풀린국내 특허폐섬유증 치료제폐활량문대현 기자 KIO-301: The Innovative Treatment for Retinitis Pigmentosa - What You Need to KnowHow AI is Revolutionizing Custom Cancer Vaccines: Insights from Neogen Logic's 2027 IND Plans관련 기사샤페론, 2세대 GPCR19 특허 확보…"신약 개발 박차"
